ASXStabl-Im clinical trial supply milestone achieved
other announcement
MEB
Medibio
- Short interest
- 0.00%
- −0.10 pp 30d
- as of 23 July 2020
- Reported shorts
- 66.8K
- Shares on issue
- 1.348B
Medibio (MEB) News
Latest articles and price-sensitive announcements with AI sentiment classification.
March 2026 Quarterly Activities Report and Appendix 4C
other announcement
Appendix 4D & Half-Year Financial Report to 31 December 2025
other announcement
December 2025 Quarterly Activities Report and Appendix 4C
other announcement
Second-tranche placement funding completed
capital_raise announcement
Change of Director's Interest Notice - David Trimboli
director_dealing announcement
Change of Director's Interest Notice - Chris Ntoumenopoulos
director_dealing announcement
Positive results from US-veteran mental health trial
other announcement
Change of Director's Interest Notice - Tony Keating
director_dealing announcement
Change of Director's Interest Notice - John Mathias
director_dealing announcement
Change of Director's Interest Notice - David Trimboli
director_dealing announcement
Change of Director's Interest Notice - Chris Ntoumenopoulos
director_dealing announcement
Notice of General Meeting & Proxy Form & Access Letter
other announcement
TRI Exercises Option to Advance Acquisition of Stabl-Im
takeover announcement
September 2025 Quarterly Activities Report and Appendix 4C
other announcement
Change in substantial holding - FIL Limited and associates
other announcement
Letter to Shareholders & Notice of AGM & Proxy Form
other announcement
US-veteran mental health trial patient recruitment complete
other announcement
Acquisition of Stabl-Im technology and Private Placement
capital_raise announcement
Positive interim results from US-veteran focused trial
other announcement
Change of Director's Interest Notice - John Mathias
director_dealing announcement